Orthofix Medical Inc.

NASDAQ:OFIX

Medical - Devices

Healthcare
$6.61 +0.33%

+$0.03 today

Market cap
$269.42M
Beta
0.71
P/E (TTM)
-6.2
EPS (TTM)
-$1.48
52W Low $9.12High $16.99

Volume 0.40M

Average 0.38M

OFIX Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

Orthofix Medical Inc.NASDAQ: OFIX

Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Free cash flow growth accelerates

Q1 FY2026 free cash flow of $28.27M (cash outflow) rose 12.5% year over year, ahead of the -24.4% change in trailing-twelve-month free cash flow. Over 3 fiscal years it compounded at -66.7% a year.

Context

  • Free cash flow amounted to 0.2% of revenue in FY2025, down 1.0 pp from a year earlier.
  • Free cash flow grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +12.5% holds above the trailing-twelve-month pace of -24.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$28.27M-260.5% QoQ
Last fiscal yearDec 2025
-$1.28M-85.9% YoY
LTMMar 2026
-$3.63M-24.4% YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+12.5%——
1 year-85.9%——
3-year CAGR-66.7%——
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
(1.28M) USD
Year-over-year change
+85.9%

Free Cash Flow vs competitors

How OFIX compares with its peers on the latest reported figures

  • OFIX's LTM Mar 2026 free cash flow of $3.63M is the smallest of the 11 companies compared; the peer median is $28.12M.
  • Its year-over-year change of -24.4% is the 5th highest of 11, against a peer median of -41.0%.
  • Free cash flow amounts to 0.4% of revenue for OFIX, versus a peer median of 18.3%.
OFIX Competitors Peer median
Free Cash Flow for OFIX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026$224.15M +60.0%+51.9%—
PACBPacific Biosciences of California, Inc.LTM Mar 2026$116.21M -36.5%-25.9%72.6%
ABSIAbsci CorporationLTM Mar 2026$98.51M +28.3%-1.2%5365.2%
LABStandard BioTools Inc.LTM Mar 2026$94.48M -23.7%-3.9%109.5%
VREXVarex Imaging CorporationLTM Apr 2026$30.8M -180.4%—3.6%
DRIODarioHealth Corp.LTM Mar 2026$25.44M -21.1%-18.6%120.0%
BFLYButterfly Network, Inc.LTM Mar 2026$18.86M -45.5%-55.9%18.3%
ESPREsperion Therapeutics, Inc.LTM Mar 2026$18.19M -81.9%-57.8%4.3%
AVNSAvanos Medical, Inc.LTM Mar 2026$7.5M -93.4%-15.6%1.0%
SIBNSI-BONE, Inc.LTM Mar 2026$5.55M -72.6%-43.8%2.7%
OFIXOrthofix Medical Inc.LTM Mar 2026$3.63M -24.4%-66.7%0.4%
Peer median (excluding OFIX) $28.12M-41.0%-18.6%18.3%

Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(38.38M)(19.75M)(151.4M)(126M)(92.19M)
Depreciation & Amortization33.1M32.08M60.6M75.96M83.26M
Deferred Income Tax24.48M314K579K1.88M223K
Stock-Based Compensation15.43M18.44M35.71M32.46M28.69M
Change in Working Capital(18.1M)(29.24M)(53.96M)(19.25M)(21.5M)
Accounts Receivables(7.05M)(6.74M)(10.41M)(9.53M)(1.58M)
Inventory619K(18.13M)(58.05M)(5.55M)(10.75M)
Accounts Payables4.25M2.28M8.64M(5.57M)2.6M
Other Working Capital(15.93M)(6.65M)5.86M1.39M(11.77M)
Other Non-Cash Items1.95M(13.39M)62.72M60.74M54.84M
Operating Cash Flow18.48M(11.54M)(45.75M)25.79M33.35M
Capital Expenditures(19.59M)(23.16M)(62.05M)(34.88M)(34.63M)
Acquisitions (Net)0(1.5M)29.42M00
Purchases of Investments(2.17M)0000
Sales of Investments0126K07.4M0
Other Investing Activities(1.25M)(1.37M)(500K)(100K)(34.6M)
Investing Cash Flow(23.01M)(24.53M)(33.13M)(27.58M)(34.6M)
Debt Repayment(537K)(2.59M)67.95M54.39M(762K)
Common Stock Issued8.82M4.34M5.13M6.26M5.93M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(11.91M)(1.82M)(7.75M)(9.94M)(5.95M)
Financing Cash Flow(3.62M)(78K)65.32M50.71M(786K)
Effect of Forex Changes(815K)(997K)619K(938K)1.41M
Net Change in Cash(8.97M)(37.15M)(12.94M)47.98M(623K)
Free Cash Flow(1.12M)(34.7M)(107.8M)(9.09M)(1.28M)

Orthofix Medical Inc.

NASDAQ:OFIX

Intrinsic Alpha fair value

Locked

Current Price

$6.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.